Search research articles
Contact Us
Filters
Showing results (981-990 of 1,158) with videos related to
Page
of 116
Sort By:
Journal of the American College of Cardiology
|
December 4, 2014
Transcatheter aortic valve replacement in bicuspid aortic valve disease
Darren Mylotte, Thierry Lefevre, Lars Søndergaard, et al.
The American Journal of Cardiology
|
October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)
Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
Masafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
Journal of the American College of Cardiology
|
April 2, 2025
Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk
Steven J Yakubov, Nicolas M Van Mieghem, Jae K Oh, et al.
European Heart Journal
|
November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes
Roland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 13, 2017
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial
Axel Linke, Jaya Chandrasekhar, Samantha Sartori, et al.
Circulation
|
April 6, 2021
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial
Alexandra J Lansky, Dean J Kereiakes, Andreas Baumbach, et al.
European Heart Journal
|
April 15, 2015
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?
Francesco Maisano, Ottavio Alfieri, Shmuel Banai, et al.
JACC. Cardiovascular Interventions
|
May 16, 2021
Impact of Residual Mitral Regurgitation on Survival After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation
Satoshi Higuchi, Mathias Orban, Lukas Stolz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study
David E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Page
of 116
Search research articles
Search
Showing results (981-990 of 1,158) with videos related to
Sort By:
Page
of 116
Journal of the American College of Cardiology
|
December 4, 2014
Transcatheter aortic valve replacement in bicuspid aortic valve disease
Darren Mylotte, Thierry Lefevre, Lars Søndergaard, et al.
The American Journal of Cardiology
|
October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)
Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
Masafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
Journal of the American College of Cardiology
|
April 2, 2025
Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk
Steven J Yakubov, Nicolas M Van Mieghem, Jae K Oh, et al.
European Heart Journal
|
November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes
Roland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 13, 2017
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial
Axel Linke, Jaya Chandrasekhar, Samantha Sartori, et al.
Circulation
|
April 6, 2021
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial
Alexandra J Lansky, Dean J Kereiakes, Andreas Baumbach, et al.
European Heart Journal
|
April 15, 2015
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?
Francesco Maisano, Ottavio Alfieri, Shmuel Banai, et al.
JACC. Cardiovascular Interventions
|
May 16, 2021
Impact of Residual Mitral Regurgitation on Survival After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation
Satoshi Higuchi, Mathias Orban, Lukas Stolz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study
David E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Page
of 116